Company Dynamic
-
South Korea's Steel Giant POSCO Invests $40 Million to Break Dependence on Chinese Graphite! Aims to Produce 347,000 Tons of Graphite Annually, Challenging China's Supply Dominance!
2024-09-04According to media reports, South Korea's leading steel and battery materials producer POSCO Group, plans to invest in Tanzania's second largest natural graphite mine project.
-
Sephora to cut jobs in China as slowdown deepens
2024-09-04The beauty retailer is cutting jobs in the face of a challenging Chinese market amid falling demand. According to the LVMH unit, "less than 3%" of its 4,000 employees in China will face layoffs.
-
BASF completes sale of Wintershall Dea E&P business to Harbour Energy
2024-09-04The exploration and production (E&P) business of Wintershall Dea (excluding Russia-related activities) was transferred to Harbour Energy plc on September 3, 2024.
-
Mundipharma International's Chinese Subsidiary's Assets Sold at a Discount Failed, $1 Billion in Cash is Difficult to Find Buyers, Valuation Bubble Burst!
2024-09-03Pharmaceutical giant Mundipharma International, part of the world-renowned Sackler Family, has failed for the second time to find a suitable buyer for its China unit in an asset disposal process restarted this year.
-
Indonesia-Africa Forum Reveals $3.5 Billion in Business Contracts, but Measles Outbreak Casts Shadow Over Bali!
2024-09-03The Indonesian president on Monday announced his country's intention to sign commercial contracts totaling $3.5 billion with African countries during the second Indonesia-Africa Forum in Bali.
-
Paint Giant PPG Resorts to ‘Selling Child to Survive’? Sells Business for $310 Million, Fate of 400 Employees Uncertain
2024-09-03On August 29, PPG Industries, a leader in the global coatings industry, announced that after a thoughtful strategic review, it has reached an agreement to sell its silicon dioxide products business to QEMETICA Corporation for approximately $310 million.
-
Sinochem Group Plans to Sell $2 Billion Stake in U.S. Shale Gas, 11-Year Investment May Go to Waste, Asian Buyers Could Step In
2024-09-03China's state-owned oil and chemicals company Sinochem plans to sell its 40% stake in a US shale gas joint venture, valuing it at more than $2bn, according to a Reuters report.
-
UCB sells mature Chinese business in a package, Middle East and Singapore capital jointly take over for nearly 5 billion yuan
2024-09-03UCB, a Belgian-based biopharmaceutical company, will sell its mature neurology and allergy business in China to Singapore-based asset management group CBC and Abu Dhabi-based investment company Mubadala for US$680 million (about 4.843 billion yuan).
-
Another business change! Mitsui Chemicals closes down styrene-acrylic resin and polyester resin related divisions
2024-09-03Mitsui Chemicals has decided to exit the styrene-acrylic resin and polyester resin related business for toner binders, mainly involving the ALMATEX™ and ALMASTAR™ brands.
-
BASF Announces Major Restructuring: Ludwigshafen Site to Cease Production of Adipic Acid and Downstream Products by 2025, Fate of 180 Employees Uncertain!
2024-09-02BASF officially announced on August 29 that as an important part of the restructuring of the integrated site in Ludwigshafen, Germany, the company has decided to stop the production of adipic acid and its related downstream products at the site.
-
Evonik's New Expansion of Methionine in Singapore: The Shutdown Controversy and Environmental Lies, with Annual Capacity Increased by 34,000 Tons, but Carbon Footprint Only Reduced by 6%?
2024-09-02Recently, Evonik officially announced that the methionine MetAMINO production base expansion project located in Singapore has been successfully completed ahead of schedule.
-
Hengrui Pharmaceuticals: The Innovation Dilemma Behind the €160 Million Windfall, as the Supercarrier Struggles to Escape the Shadow of the Old Way
2024-09-02On August 21, 2024, Hengrui Pharmaceutical announced its remarkable financial results: in the half year, the company's revenue reached 13.601 billion yuan, an increase of 21.78% over the same period last year;
-
Johnson & Johnson's New Drug Comes Under Fire: 4.7-Point Improvement Fails to Ease the Plight of gMG Patients, Can the Efficacy Stand Up to Market Tests?
2024-09-02The study was a double-blind, placebo-controlled trial that enrolled a large number of patients with AChR+, MuSK+, and/or LRP4+, who accounted for approximately 95% of the total number of patients with gMG.
-
Sanofi's Diabetes Drug Raises Concerns, Type1 Diabetes Treatment May Be a Trap: Can It Really Delay Disease Onset by 3 Years?
2024-09-02On August 28, the Center for Drug Evaluation (CDE) under the National Medical Products Administration (NMPA) of China announced on its official website that Sanofi's application for the marketing of Tilizumab injection has been officially accepted.
-
Merck's PD-1 Miracle Drug Keytruda Faces Setback: Three Studies on Lung and Skin Cancer Announce Failure, Patients at Higher Risk!
2024-09-02The interim analysis showed that the combination of Keytruda and stereotactic radiotherapy (SBRT) did not significantly improve event-free survival or overall survival in patients with stage I or II non-small cell lung cancer (NSCLC)
-
Kolmar Korea accelerates North American expansion, plans second plant in the U.S.
2024-09-02Kolmar Korea plans to build a second plant in the U.S. early next year. To this end, the cosmetics maker has appointed a new head of North American operations and a global chief commercial officer (GCCO).
-
PPG expands Malaysia plant to manufacture low-friction coatings
2024-09-02PPG announced it has expanded its facility in Petaling Jaya, Malaysia, to produce nonstick coatings for cookware, industrial bakeware and low-friction applications.
-
Nouryon and Brenntag enter into distribution agreement for cleaning ingredients in Mexico
2024-08-30Nouryon has announced a strategic distribution agreement with Brenntag Specialties, a global market leader in chemicals and ingredients distribution, to bring Nouryon’s cleaning portfolio to Mexico.
-
BASF to shut down adipic acid, CDon and CPon production units at Ludwigshafen site in first half of 2025
2024-08-30BASF will stop the production of adipic acid, cyclododecanone (CDon) and cyclopentanone (CPon) at the Ludwigshafen site.
-
$310 million! PPG sells silica business!
2024-08-30PPG, a global leader in paints, coatings and specialty materials, announced on August 29 that it will sell its silica products business to QEMETICA, a privately held manufacturer of soda ash, silicates and other specialty chemicals.
Hot News
-
Muriatic Acid vs Hydrochloric Acid: What's the Difference?
-
BASF announced that due to force majeure, this product has ceased supply!
-
Is pyrethrin and permethrin the same-What are the key differences
-
Is HFC134a the same as R134a | Core Differences and Applications
-
What Is The Difference Between Washing Soda And Soda Ash
-
Acetone vs Alcohol: Key Differences, Uses, and Safety Compared
-
Lysinate Glycinate vs Glycinate: Key Differences and Benefits
-
Polypropylene vs Polycarbonate: What Is the Difference?
-
The merger and reorganization of ChemChina and Sinochem is in progress
-
What is the Difference Between NaCl and NaCl2?